SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-018811
Filing Date
2024-02-22
Accepted
2024-02-22 16:27:58
Documents
116
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K bbio-20231231.htm   iXBRL 10-K 5275537
2 EX-10.31 bbio-ex10_31.htm EX-10.31 164441
3 EX-10.39 bbio-ex10_39.htm EX-10.39 24766
4 EX-19 bbio-ex19.htm EX-19 149870
5 EX-21 bbio-ex21.htm EX-21 45790
6 EX-23.1 bbio-ex23_1.htm EX-23.1 9510
7 EX-31.1 bbio-ex31_1.htm EX-31.1 20646
8 EX-31.2 bbio-ex31_2.htm EX-31.2 20677
9 EX-32.1 bbio-ex32_1.htm EX-32.1 8504
10 EX-32.2 bbio-ex32_2.htm EX-32.2 8640
11 EX-97 bbio-ex97.htm EX-97 41388
12 GRAPHIC img8472127_0.jpg GRAPHIC 4698
13 GRAPHIC img187994693_0.jpg GRAPHIC 104046
14 GRAPHIC img187994693_1.jpg GRAPHIC 41707
15 GRAPHIC img187994693_2.jpg GRAPHIC 20150
16 GRAPHIC img187994693_3.jpg GRAPHIC 23616
17 GRAPHIC img187994693_4.jpg GRAPHIC 68892
18 GRAPHIC img187994693_5.jpg GRAPHIC 27396
  Complete submission text file 0000950170-24-018811.txt   21537579

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bbio-20231231.xsd EX-101.SCH 2763176
118 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20231231_htm.xml XML 3806939
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38959 | Film No.: 24665262
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)